Vaylen Review
Best for: GLP-1-focused care with oral and injectable options across all 50 states
Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy. LegitScript certified. Licensed clinicians in all 50 states.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Included
Coaching
Included
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Vaylen is a solid telehealth option with balanced features and pricing.
Vaylen at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Ozempic, Zepbound
- Starting price
- $179/mo
- What's included
- Medication · Consult · Shipping · Labs · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Vaylen
Each dimension is scored algorithmically from Vaylen’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $179/mo, Vaylen runs about 5% above the $170 median for GLP-1 providers.
Effectiveness25%
8.4/10Vaylen offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.3/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
8.0/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
8.2/10Vaylen treats patients in all 50 states.
Support10%
7.1/10Coaching/dietitian access included.
How we verified this Vaylen review
Last checked 2026-06-06- Confirmed current pricing across 5 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Vaylen offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Vaylen's current pricing and active discounts before you decide.
What we like
- Pure GLP-1 specialist — not a multi-category telehealth platform
- All 50 states coverage with licensed clinicians
- Both compounded and brand-name options (Ozempic, Wegovy, Zepbound)
- Oral GLP-1 option (compounded dissolvable tablets) for needle-averse patients
- LegitScript certified
- Transparent pricing — no hidden costs, no insurance required
- Continuous coaching and lab support included
Watch-outs
- Compounded semaglutide at $179/mo is mid-range (not the cheapest)
- Brand-name options at near-retail pricing ($997-$1,086/mo)
Vaylen: a GLP-1-only clinic that does one thing
Most telehealth brands that sell weight-loss medication also sell hair pills, sleep aids, and a dozen other things. Vaylen doesn't. It is a pure GLP-1 specialist — its entire business is getting people on semaglutide and tirzepatide and keeping them there safely. If you want a focused clinic rather than a general telehealth marketplace, that single-mindedness is the main reason to look here. At $179 a month for compounded semaglutide, it lands right around the category median of $170, so you're paying a fair middle-of-the-road rate for a service that includes more than the medication alone.
How the pricing actually works
Vaylen charges one predictable monthly fee per medication that bundles the provider visits, the medication itself, ongoing lab monitoring, coaching, and free shipping. There is no separate consult fee tacked on, no membership layer, and no insurance to wrangle — it's a flat cash price. Compounded semaglutide runs $179 a month. Compounded tirzepatide costs a step more in the low two-hundreds, and the compounded oral GLP-1 sits a little above that. Prices are quoted as 'starting at' rates rather than locked-in numbers, so your exact cost can move with your dose — confirm the current figure at checkout before you commit.
One honest note: Vaylen is not the cheapest compounded semaglutide on the market. Several competitors undercut its $179 headline. What you're paying the small premium for is the bundled labs, coaching, and the single-focus model — not a rock-bottom price.
Compounded versus brand — and the real cost gap
Vaylen sells both lanes. The compounded options are where the value is and where almost everyone will land. It also offers brand-name Ozempic and Zepbound, but at close to retail — both sit near or above the thousand-dollar-a-month mark without insurance. That's not a markup quirk; it's simply what these branded pens cost cash-pay almost everywhere. If your insurance covers a brand GLP-1, you'll do far better filling it at a regular pharmacy than paying Vaylen's near-list cash rate. The brand option here is really a convenience for people who specifically want the pen and are paying out of pocket anyway.
The oral option for the needle-averse
The feature that genuinely separates Vaylen from the pack is its compounded oral GLP-1 — a dissolvable tablet for people who can't stomach the idea of a weekly injection. It's priced a bit higher than the compounded shots, which is the usual trade-off for oral formulations, but for someone who would otherwise never start treatment because of a needle phobia, that option is the whole reason to pick this clinic.
What's included, and the 50-state reach
The monthly fee is not just for pills. Vaylen states it covers provider visits, medication management, regularly monitored safety labs, ongoing coaching, and shipping — all of it folded into the one price. That lab-monitoring piece matters: ongoing bloodwork is how a responsible GLP-1 program catches problems early, and not every cheap compounding shop bothers.
- Licensed clinicians available in all 50 states — no geographic gaps
- Compounded semaglutide, compounded tirzepatide, and a compounded oral GLP-1
- Brand-name Ozempic, Wegovy, and Zepbound for cash-pay patients who want the pen
- Safety labs, coaching, and free shipping bundled into the monthly fee
- No insurance required and no hidden add-on consult charge
Trust and oversight
Vaylen is LegitScript certified, which is a meaningful signal — LegitScript vets telehealth and pharmacy operations for legitimacy and is the standard most ad platforms require before they'll run health advertising. There are no FDA warning letters on file against Vaylen in our records. The clinic also doesn't name its specific compounding pharmacy partners publicly, so we can't independently confirm which 503A or 503B facility fills its compounded prescriptions — worth asking directly if pharmacy accreditation is a dealbreaker for you. For how we weigh certification and oversight, see our scoring methodology.
Who should choose Vaylen — and who shouldn't
Choose Vaylen if you want a clinic that does GLP-1 and nothing else, you're paying cash, you value bundled labs and coaching over chasing the absolute lowest sticker price, or you specifically need the oral tablet because injections are a non-starter. Its all-50-state coverage also makes it a safe pick if you live somewhere other telehealth clinics skip.
Skip it if your only goal is the cheapest possible compounded semaglutide — you can find that elsewhere for less. Skip it too if you have insurance that covers brand-name GLP-1s, because Vaylen's near-retail brand pricing makes no sense when your plan would cover the same pen for a fraction of that.
Bottom line
Vaylen is a focused, transparently priced GLP-1 clinic that does the fundamentals right: one flat monthly fee, real lab monitoring, coaching, nationwide coverage, LegitScript certification, and an oral option most competitors don't offer. It won't win a pure price war, and its brand-name pricing is only for cash-pay patients who insist on the pen. But for someone who wants a no-nonsense, single-purpose weight-loss clinic with included support and a needle-free path, the $179-a-month compounded plan is a solid, fairly priced choice.
For a side-by-side, Sunlight ($159/month) and Bodybuilding Health+ ($179/month) are the most comparable options to weigh against Vaylen.
Ready to start with Vaylen?
Starting at $179/month. See current pricing and start your free consultation.
Alternatives to Vaylen
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Vaylen review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Vaylen?
Starting at $179/month. See current pricing and start your free consultation.